CN105362548A - Traditional Chinese medicine for treating allergic asthma - Google Patents

Traditional Chinese medicine for treating allergic asthma Download PDF

Info

Publication number
CN105362548A
CN105362548A CN201510864904.3A CN201510864904A CN105362548A CN 105362548 A CN105362548 A CN 105362548A CN 201510864904 A CN201510864904 A CN 201510864904A CN 105362548 A CN105362548 A CN 105362548A
Authority
CN
China
Prior art keywords
parts
fructus
radix
grams
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510864904.3A
Other languages
Chinese (zh)
Inventor
甘红梅
卢艳霞
李荣华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Accessories During Binzhou People's Hospital
Original Assignee
Accessories During Binzhou People's Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accessories During Binzhou People's Hospital filed Critical Accessories During Binzhou People's Hospital
Priority to CN201510864904.3A priority Critical patent/CN105362548A/en
Publication of CN105362548A publication Critical patent/CN105362548A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicine and particularly relates to traditional Chinese medicine for treating allergic asthma. The traditional Chinese medicine for treating the allergic asthma is characterized by comprising, by weight, 4-9 parts of rhizoma belamcandae, 4-9 parts of almond, 4-9 parts of radix asteris, 4-9 parts of tussilago farfara, 5-10 parts of centipeda minima, 5-10 parts of tribulus terrestris, 5-10 parts of bombyx batryticatus, 5-10 parts of rhizoma pinellinae praeparata, 5-10 parts of fructus schizandrae, 5-10 parts of semen raphanin, 5-10 parts of radix glycyrrhizae, 10-45 parts of radix astragali, 10-45 parts of radix sileris, 10-45 parts of rhizoma atractylodis macrocephalae, 5-20 parts of vervain, 5-20 parts of selaginella tamariscina, 5-10 parts of uncaria, 5-10 parts of arisaema cum bile, 5-12 parts of trichosanthes kirilowii, 3-6 parts of fructus perillae and 3-6 parts of fructus mume. The traditional Chinese medicine for treating the allergic asthma has the advantages that the traditional Chinese medicine raw materials are combined to achieve synergic effects of ventilating the lung and relieving cough and relieving cough and asthma, air passages are eliminated fundamentally to allow in-vivo environment immune balance to recover thoroughly, lung functions are activated and reconstructed, and the allergic asthma can be treated.

Description

A kind of Chinese medicine for the treatment of allergic asthma
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of allergic asthma.
Background technology
Allergic asthma is people to some predetermined substance or with the characteristic body constitution reaction that seasonal variations occurs, be embodied in that nasopharynx is itched, sneeze, cough etc., classical symptom be ictally to pant, wheezing, symptom can disappear voluntarily or after taking medicine after a couple of days.Allergic asthma is taken seriously because of its seriousness and hazardness, can with having a strong impact on its work and life all the life as ignored treatment.The reason of allergic asthma is roughly divided into following several: inhalation (inhalatio) allergy causes asthma, as dirt demodicid mite, pollen etc.; The infection of respiratory tract causes allergic asthma; Some food becomes the anaphylactogen of allergic asthma because of the difference of individual physique; The change of weather can cause allergic asthma; Patient's psychokinesia causes allergic asthma; Move and too drasticly cause allergic asthma.Therapeutic modality about allergic asthma rests in the past: show effect-treat-alleviate-stop the old model controlled-showing effect, and all not good for the western medicines in treatment effect of allergic asthma in existing medicine.
Summary of the invention
The object of the invention is to overcome the defect of above-mentioned existence and make up the deficiencies in the prior art a kind of Chinese medicinal components for the treatment of allergic asthma is provided.Technical scheme of the present invention is: a kind of Chinese medicine for the treatment of allergic asthma, consist of the following composition by weight: Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 4 ~ 9 parts, Herba Centipedae, Fructus Tribuli are 5 ~ 10 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 5 ~ 10 parts, and the Radix Astragali, Radix Saposhnikoviae are 10 ~ 45 parts, and the Rhizoma Atractylodis Macrocephalae is 10 ~ 45 parts, Herba Verbenae, Herba Selaginellae are 5 ~ 20 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 5 ~ 10 parts, and Fructus Trichosanthis is 5 ~ 12 parts, and Fructus Perillae, Fructus Mume are 3 ~ 6 parts.
A kind of Chinese medicine for the treatment of allergic asthma, preferably Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 5 ~ 8 parts, Herba Centipedae, Fructus Tribuli are 5 ~ 8 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 5 ~ 8 parts, and the Radix Astragali, Radix Saposhnikoviae are 10 ~ 15 parts, and the Rhizoma Atractylodis Macrocephalae is 20 ~ 40 parts, Herba Verbenae, Herba Selaginellae are 5 ~ 15 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 5 ~ 8 parts, and Fructus Trichosanthis is 7 ~ 9 parts, and Fructus Perillae, Fructus Mume are 4 ~ 5 parts.
A kind of Chinese medicine for the treatment of allergic asthma, preferably Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 5 parts, Herba Centipedae, Fructus Tribuli are 6 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 5 parts, and the Radix Astragali, Radix Saposhnikoviae are 10 parts, and the Rhizoma Atractylodis Macrocephalae is 30 parts, Herba Verbenae, Herba Selaginellae are 10 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 8 parts, and Fructus Trichosanthis is 7 parts, and Fructus Perillae, Fructus Mume are 4 parts.
A kind of Chinese medicine for the treatment of allergic asthma, preferably Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 8 parts, Herba Centipedae, Fructus Tribuli are 6 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 5 parts, and the Radix Astragali, Radix Saposhnikoviae are 12 parts, and the Rhizoma Atractylodis Macrocephalae is 36 parts, Herba Verbenae, Herba Selaginellae are 12 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 5 parts, and Fructus Trichosanthis is 8 parts, and Fructus Perillae, Fructus Mume are 4 parts.
A kind of Chinese medicine for the treatment of allergic asthma, preferably Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 8 parts, Herba Centipedae, Fructus Tribuli are 8 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 8 parts, and the Radix Astragali, Radix Saposhnikoviae are 13 parts, and the Rhizoma Atractylodis Macrocephalae is 39 parts, Herba Verbenae, Herba Selaginellae are 7 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 6 parts, and Fructus Trichosanthis is 8 parts, and Fructus Perillae, Fructus Mume are 4 parts.
A kind of Chinese medicine for the treatment of allergic asthma, preferably Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 5 parts, Herba Centipedae, Fructus Tribuli are 6 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 8 parts, and the Radix Astragali, Radix Saposhnikoviae are 10 parts, and Fructus Tribuli is 30 parts, Herba Verbenae, Herba Selaginellae are 10 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 7 parts, and Fructus Trichosanthis is 8 parts, Fructus Perillae, Fructus Mume 5 parts.
A kind of Chinese medicine for the treatment of allergic asthma, preferably Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 8 parts, Herba Centipedae, Fructus Tribuli are 7 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 7 parts, and the Radix Astragali, Radix Saposhnikoviae are 10 parts, and the Rhizoma Atractylodis Macrocephalae is 30 parts, Herba Verbenae, Herba Selaginellae are 11 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 7 parts, and Fructus Trichosanthis is 7 parts, and Fructus Perillae, Fructus Mume are 4 parts.
A kind of Chinese medicine for the treatment of allergic asthma, preferably Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 6 parts, Herba Centipedae, Fructus Tribuli are 7 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 8 parts, the Radix Astragali, Radix Saposhnikoviae 11 parts, and the Rhizoma Atractylodis Macrocephalae is 33 parts, Herba Verbenae, Herba Selaginellae are 12 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile 6 parts, Fructus Trichosanthis is 6 parts, and Fructus Perillae, Fructus Mume are 5 parts.
Beneficial effect of the present invention is: drug effect of the present invention has synergism, play logical lung cough-relieving, the effect of relieving cough and asthma, fundamentally eliminate air flue and the immunologic balance of health environment is thoroughly recovered, pulmonary function is reproduced in activation, thus reaches the object for the treatment of allergic asthma.Clinical experiment shows, takes the Chinese medicine that the present invention treats allergic asthma, reaches as high as 94.30% to the cure rate of this disease, and to human non-toxic's side effect.
Detailed description of the invention
embodiment 1
A kind of Chinese medicine for the treatment of allergic asthma, be made up of the Chinese medicine ingredients of following weight: Rhizoma Belamcandae 5 grams, 5 grams, Semen Armeniacae Amarum, Radix Asteris 5 grams, Flos Farfarae 5 grams, Herba Centipedae 6 grams, Fructus Tribuli 6 grams, Bombyx Batryticatus 5 grams, Rhizoma Pinelliae Preparatum 5 grams, Fructus Schisandrae Chinensis 5 grams, Semen Raphani 5 grams, 5 grams, Radix Glycyrrhizae, the Radix Astragali 10 grams, Radix Saposhnikoviae 10 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Herba Verbenae 5 grams, Herba Selaginellae 10 grams, Ramulus Uncariae Cum Uncis 8 grams, Arisaema Cum Bile 8 grams, Fructus Trichosanthis 7 grams, Fructus Perillae 4 grams, Fructus Mume 4 grams.
Preparation and instructions of taking: first by the Impurity removal of each raw material, all taste medicines are put into marmite and added water 600 milliliters, decoct half an hour, potion on the one, takes at twice, within 10 days, is a course for the treatment of.
Below in conjunction with clinical data and model case, the present invention will be described in detail.
1 clinical data: patient 130 example being selected from a certain institute of traditional Chinese medicine allergic asthma carries out tracking treatment, 70 these Chinese medicines of example are wherein divided to carry out treating (treatment group), 60 examples carry out western medical treatment (contrast groups), and wherein the mean age for the treatment of group is 50 years old, and the mean age of contrast groups is 48 years old.
2 treatment: treatment group, take the embodiment of the present invention 1 medicine, every day potion, every agent twice 10 days is a course for the treatment of; Contrast groups, Roxithromycin Tablets is oral, each 0.15g, and every day twice, hismanal tablet is oral, each 9mg, once a day, within 10 days, is a course for the treatment of.
3 curative effects are passed judgment on and standard:
Cure: wheezing symptoms and pulmonary's wheezing sound disappear, and do not need any medicine, keep asymptomatic more than 1 year.
Effective: wheezing symptoms and pulmonary's wheezing sound are clearly better.
Effective: wheezing symptoms and pulmonary's wheezing sound take a favorable turn.
Invalid: wheezing symptoms and pulmonary's wheezing sound are without improvement or increase the weight of.
4 therapeutic outcomes: two groups of therapeutic outcomes are as shown in table 1
Table 1 is two groups of cure rate synopsis
embodiment 2
A kind of Chinese medicine for the treatment of allergic asthma, be made up of the Chinese medicine ingredients of following weight: Rhizoma Belamcandae 8 grams, 8 grams, Semen Armeniacae Amarum, Radix Asteris 8 grams, Flos Farfarae 8 grams, Herba Centipedae 6 grams, Fructus Tribuli 6 grams, Bombyx Batryticatus 5 grams, Rhizoma Pinelliae Preparatum 5 grams, Fructus Schisandrae Chinensis 5 grams, Semen Raphani 5 grams, 5 grams, Radix Glycyrrhizae, the Radix Astragali 12 grams, Radix Saposhnikoviae 12 grams, the Rhizoma Atractylodis Macrocephalae 36 grams, Herba Verbenae 12 grams, Herba Selaginellae 12 grams, Ramulus Uncariae Cum Uncis 5 grams, Arisaema Cum Bile 5 grams, Fructus Trichosanthis 8 grams, Fructus Perillae 4 grams, Fructus Mume 4 grams.
Preparation and instructions of taking are with embodiment 1
Below in conjunction with clinical data and model case, the present invention will be described in detail.
1 clinical data: patient 126 example being selected from the allergic asthma of certain institute of traditional Chinese medicine carries out tracking treatment, 66 these Chinese medicines of example are wherein divided to carry out treating (treatment group), 60 examples carry out western medical treatment (contrast groups), and wherein the mean age for the treatment of group is 56 years old, and the mean age of contrast groups is 52 years old.
2 treatment: treatment group, take the embodiment of the present invention 2 medicine, every day potion, every agent twice 10 days is a course for the treatment of; Contrast groups, Roxithromycin Tablets is oral, each 0.15g, and every day twice, hismanal tablet is oral, each 9mg, once a day, within 10 days, is a course for the treatment of.
3 curative effects judges and standard are with embodiment 1
4 therapeutic outcomes: two groups of therapeutic outcomes are as shown in table 2
Table 2 is two groups of cure rate synopsis
embodiment 3
A kind of Chinese medicine for the treatment of allergic asthma, be made up of the Chinese medicine ingredients of following weight: Rhizoma Belamcandae 8 grams, 8 grams, Semen Armeniacae Amarum, Radix Asteris 8 grams, Flos Farfarae 8 grams, Herba Centipedae 8 grams, Fructus Tribuli 8 grams, Bombyx Batryticatus 8 grams, Rhizoma Pinelliae Preparatum 8 grams, Fructus Schisandrae Chinensis 8 grams, Semen Raphani 8 grams, 8 grams, Radix Glycyrrhizae, the Radix Astragali 13 grams, Radix Saposhnikoviae 13 grams, the Rhizoma Atractylodis Macrocephalae 39 grams, Herba Verbenae 7 grams, Herba Selaginellae 7 grams, Ramulus Uncariae Cum Uncis 6 grams, Arisaema Cum Bile 6 grams, Fructus Trichosanthis 8 grams, Fructus Perillae 4 grams, Fructus Mume 4 grams.
Preparation and instructions of taking are with embodiment 1
Below in conjunction with clinical data and model case, the present invention will be described in detail.
1 clinical data: patient 100 example being selected from the allergic asthma of certain institute of traditional Chinese medicine carries out tracking treatment, 50 these Chinese medicines of example are wherein divided to carry out treating (treatment group), 50 examples carry out western medical treatment (contrast groups), and wherein the mean age for the treatment of group is 40 years old, and the mean age of contrast groups is 43 years old.
2 treatment: treatment group, take the embodiment of the present invention 3 medicine, every day potion, every agent twice 10 days is a course for the treatment of; Contrast groups, Roxithromycin Tablets is oral, each 0.15g, and every day twice, hismanal tablet is oral, each 9mg, once a day, within 10 days, is a course for the treatment of.
3 curative effects judges and standard are with embodiment 1
4 therapeutic outcomes: two groups of therapeutic outcomes are as shown in table 3
Table 3 is two groups of cure rate synopsis
embodiment 4
A kind of Chinese medicine for the treatment of allergic asthma, be made up of the Chinese medicine ingredients of following weight: Rhizoma Belamcandae 5 grams, 5 grams, Semen Armeniacae Amarum, Radix Asteris 5 grams, Flos Farfarae 5 grams, Herba Centipedae 6 grams, Fructus Tribuli 6 grams, Bombyx Batryticatus 8 grams, Rhizoma Pinelliae Preparatum 8 grams, Fructus Schisandrae Chinensis 8 grams, Semen Raphani 8 grams, 8 grams, Radix Glycyrrhizae, the Radix Astragali 10 grams, Radix Saposhnikoviae 10 grams, Fructus Tribuli 30 grams, Herba Verbenae 10 grams, Herba Selaginellae is 10 grams, Ramulus Uncariae Cum Uncis 7 grams, Arisaema Cum Bile 7 grams, Fructus Trichosanthis 8 grams, Fructus Perillae 5 grams, Fructus Mume 5 grams.
Preparation and instructions of taking are with embodiment 1
Below in conjunction with clinical data and model case, the present invention will be described in detail.
1 clinical data: patient 125 example being selected from the allergic asthma of certain institute of traditional Chinese medicine carries out tracking treatment, 65 these Chinese medicines of example are wherein divided to carry out treating (treatment group), 60 examples carry out western medical treatment (contrast groups), and wherein the mean age for the treatment of group is 40 years old, and the mean age of contrast groups is 43 years old.
2 treatment: treatment group, take the embodiment of the present invention 4 medicine, every day potion, every agent twice 10 days is a course for the treatment of; Contrast groups, Roxithromycin Tablets is oral, each 0.15g, and every day twice, hismanal tablet is oral, each 9mg, once a day, within 10 days, is a course for the treatment of.
3 curative effects judges and standard are with embodiment 1
4 therapeutic outcomes: two groups of therapeutic outcomes are as shown in table 4
Table 4 is two groups of cure rate synopsis
embodiment 5
A kind of Chinese medicine for the treatment of allergic asthma, be made up of the Chinese medicine ingredients of following weight: Rhizoma Belamcandae 8 grams, 8 grams, Semen Armeniacae Amarum, Radix Asteris 8 grams, Flos Farfarae are 8 grams, Herba Centipedae 7 grams, Fructus Tribuli are 7 grams, and Bombyx Batryticatus 7 grams, Rhizoma Pinelliae Preparatum 7 grams, Fructus Schisandrae Chinensis 7 grams, Semen Raphani 7 grams, Radix Glycyrrhizae are 7 grams, the Radix Astragali 10 grams, Radix Saposhnikoviae 10 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Herba Verbenae 11 grams, Herba Selaginellae 11 grams, Ramulus Uncariae Cum Uncis 7 grams, Arisaema Cum Bile 7 grams, Fructus Trichosanthis 7 grams, Fructus Perillae 4 grams, Fructus Mume 4 grams.
Preparation and instructions of taking are with embodiment 1
Below in conjunction with clinical data and model case, the present invention will be described in detail.
1 clinical data: patient 90 example being selected from the allergic asthma of certain institute of traditional Chinese medicine carries out tracking treatment, 45 these Chinese medicines of example are wherein divided to carry out treating (treatment group), 45 examples carry out western medical treatment (contrast groups), and wherein the mean age for the treatment of group is 55 years old, and the mean age of contrast groups is 52 years old.
2 treatment: treatment group, take the embodiment of the present invention 5 medicine, every day potion, every agent twice 10 days is a course for the treatment of; Contrast groups, Roxithromycin Tablets is oral, each 0.15g, and every day twice, hismanal tablet is oral, each 9mg, once a day, within 10 days, is a course for the treatment of.
3 curative effects judges and standard are with embodiment 1
4 therapeutic outcomes: two groups of therapeutic outcomes are as shown in table 5
embodiment 6
A kind of Chinese medicine for the treatment of allergic asthma, be made up of the Chinese medicine ingredients of following weight: Rhizoma Belamcandae 6 grams, 6 grams, Semen Armeniacae Amarum, Radix Asteris 6 grams, Flos Farfarae 6 grams, Herba Centipedae 7 grams, Fructus Tribuli 7 grams, Bombyx Batryticatus 8 grams, Rhizoma Pinelliae Preparatum 8 grams, Fructus Schisandrae Chinensis 8 grams, Semen Raphani 8 grams, 8 grams, Radix Glycyrrhizae, the Radix Astragali 11 grams, Radix Saposhnikoviae 11 grams, the Rhizoma Atractylodis Macrocephalae 33 grams, Herba Verbenae 12 grams, Herba Selaginellae 12 grams, Ramulus Uncariae Cum Uncis 6 grams, Arisaema Cum Bile 6 grams, Fructus Trichosanthis 6 grams, Fructus Perillae 5 grams, Fructus Mume 5 grams.
Preparation and instructions of taking are with embodiment 1
Below in conjunction with clinical data and model case, the present invention will be described in detail.
1 clinical data: patient 123 example being selected from the allergic asthma of certain institute of traditional Chinese medicine carries out tracking treatment, 60 these Chinese medicines of example are wherein divided to carry out treating (treatment group), 63 examples carry out western medical treatment (contrast groups), and wherein the mean age for the treatment of group is 52 years old, and the mean age of contrast groups is 50 years old.
2 treatment: treatment group, take the embodiment of the present invention 6 medicine, every day potion, every agent twice 10 days is a course for the treatment of; Contrast groups, Roxithromycin Tablets is oral, each 0.15g, and every day twice, hismanal tablet is oral, each 9mg, once a day, within 10 days, is a course for the treatment of.
3 curative effects judges and standard are with embodiment 1
4 therapeutic outcomes: two groups of therapeutic outcomes are as shown in table 6
Table 6 is two groups of cure rate synopsis
In sum, therapeutic outcome shows, and treatment group and matched group volume total effective rate have obvious difference, and have no side effect to patient through the Drug therapy of clinical observation treatment group.The present invention treats the Chinese medicine of allergic asthma, through clinical trial, shows that it can effectively improve patients symptomatic, sign, and without obvious toxic-side effects.

Claims (8)

1. treat the Chinese medicine of allergic asthma for one kind, it is characterized in that: the present invention is made up of following ingredient by weight: Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 4 ~ 9 parts, Herba Centipedae, Fructus Tribuli are 5 ~ 10 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 5 ~ 10 parts, and the Radix Astragali, Radix Saposhnikoviae are 10 ~ 45 parts, and the Rhizoma Atractylodis Macrocephalae is 10 ~ 45 parts, Herba Verbenae, Herba Selaginellae are 5 ~ 20 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 5 ~ 10 parts, and Fructus Trichosanthis is 5 ~ 12 parts, and Fructus Perillae, Fructus Mume are 3 ~ 6 parts.
2. the Chinese medicine for the treatment of allergic asthma according to claim 1, it is characterized in that: be made up of following ingredient: Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 5 ~ 8 parts, Herba Centipedae, Fructus Tribuli are 5 ~ 8 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 5 ~ 8 parts, and the Radix Astragali, Radix Saposhnikoviae are 10 ~ 15 parts, and the Rhizoma Atractylodis Macrocephalae is 20 ~ 40 parts, Herba Verbenae, Herba Selaginellae are 5 ~ 15 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 5 ~ 8 parts, and Fructus Trichosanthis is 7 ~ 9 parts, and Fructus Perillae, Fructus Mume are 4 ~ 5 parts.
3. the Chinese medicine for the treatment of allergic asthma according to claim 1, it is characterized in that: be made up of following ingredient: Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 5 parts, Herba Centipedae, Fructus Tribuli are 6 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 5 parts, and the Radix Astragali, Radix Saposhnikoviae are 10 parts, and the Rhizoma Atractylodis Macrocephalae is 30 parts, Herba Verbenae, Herba Selaginellae are 10 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 8 parts, and Fructus Trichosanthis is 7 parts, and Fructus Perillae, Fructus Mume are 4 parts.
4. the Chinese medicine for the treatment of allergic asthma according to claim 1, it is characterized in that: be made up of following ingredient: Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 8 parts, Herba Centipedae, Fructus Tribuli are 6 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 5 parts, and the Radix Astragali, Radix Saposhnikoviae are 12 parts, and the Rhizoma Atractylodis Macrocephalae is 36 parts, Herba Verbenae, Herba Selaginellae are 12 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 5 parts, and Fructus Trichosanthis is 8 parts, and Fructus Perillae, Fructus Mume are 4 parts.
5. the Chinese medicine for the treatment of allergic asthma according to claim 1, it is characterized in that: be made up of following ingredient: Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 8 parts, Herba Centipedae, Fructus Tribuli are 8 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 8 parts, and the Radix Astragali, Radix Saposhnikoviae are 13 parts, and the Rhizoma Atractylodis Macrocephalae is 39 parts, Herba Verbenae, Herba Selaginellae are 7 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 6 parts, and Fructus Trichosanthis is 8 parts, and Fructus Perillae, Fructus Mume are 4 parts.
6. the Chinese medicine for the treatment of allergic asthma according to claim 1, it is characterized in that: be made up of following ingredient: Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 5 parts, Herba Centipedae, Fructus Tribuli are 6 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 8 parts, and the Radix Astragali, Radix Saposhnikoviae are 10 parts, and Fructus Tribuli is 30 parts, Herba Verbenae, Herba Selaginellae are 10 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 7 parts, and Fructus Trichosanthis is 8 parts, and Fructus Perillae, Fructus Mume are 5 parts.
7. the Chinese medicine for the treatment of allergic asthma according to claim 1, it is characterized in that: be made up of following ingredient: Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 8 parts, Herba Centipedae, Fructus Tribuli are 7 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 7 parts, and the Radix Astragali, Radix Saposhnikoviae are 10 parts, and the Rhizoma Atractylodis Macrocephalae is 30 parts, Herba Verbenae, Herba Selaginellae are 11 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 7 parts, and Fructus Trichosanthis is 7 parts, and Fructus Perillae, Fructus Mume are 4 parts.
8. the Chinese medicine for the treatment of allergic asthma according to claim 1, it is characterized in that: be made up of following ingredient: Rhizoma Belamcandae, Semen Armeniacae Amarum, Radix Asteris, Flos Farfarae are 6 parts, Herba Centipedae, Fructus Tribuli are 7 parts, Bombyx Batryticatus, Rhizoma Pinelliae Preparatum, Fructus Schisandrae Chinensis, Semen Raphani, Radix Glycyrrhizae are 8 parts, and the Radix Astragali, Radix Saposhnikoviae are 11 parts, and the Rhizoma Atractylodis Macrocephalae is 33 parts, Herba Verbenae, Herba Selaginellae are 12 parts, Ramulus Uncariae Cum Uncis, Arisaema Cum Bile are 6 parts, and Fructus Trichosanthis is 6 parts, and Fructus Perillae, Fructus Mume are 5 parts.
CN201510864904.3A 2015-12-01 2015-12-01 Traditional Chinese medicine for treating allergic asthma Pending CN105362548A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510864904.3A CN105362548A (en) 2015-12-01 2015-12-01 Traditional Chinese medicine for treating allergic asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510864904.3A CN105362548A (en) 2015-12-01 2015-12-01 Traditional Chinese medicine for treating allergic asthma

Publications (1)

Publication Number Publication Date
CN105362548A true CN105362548A (en) 2016-03-02

Family

ID=55365497

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510864904.3A Pending CN105362548A (en) 2015-12-01 2015-12-01 Traditional Chinese medicine for treating allergic asthma

Country Status (1)

Country Link
CN (1) CN105362548A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109276533A (en) * 2018-11-30 2019-01-29 江苏贝塔仕生物科技有限公司 A kind of pair of asthma has medicative mildy wash

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104001019A (en) * 2013-10-29 2014-08-27 陈丽艳 Traditional Chinese medicinal composition for treating seasonal allergic rhinitis
CN104666847A (en) * 2013-11-28 2015-06-03 青岛食之礼中草药研究所 Traditional Chinese medicine decoction for treating allergic asthma

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104001019A (en) * 2013-10-29 2014-08-27 陈丽艳 Traditional Chinese medicinal composition for treating seasonal allergic rhinitis
CN104666847A (en) * 2013-11-28 2015-06-03 青岛食之礼中草药研究所 Traditional Chinese medicine decoction for treating allergic asthma

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
朱溅石等主编: "《名方妙用》", 31 January 2014, 人民军医出版社 *
马绍泉: "润肺抗敏煎在治疗支气管哮喘中的应用", 《青海医药杂志》 *
骆忠元: "从痰、饮论治哮病", 《中医研究》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109276533A (en) * 2018-11-30 2019-01-29 江苏贝塔仕生物科技有限公司 A kind of pair of asthma has medicative mildy wash

Similar Documents

Publication Publication Date Title
CN102743737B (en) Chinese medicinal preparation for effectively treating tracheitis
CN102416095A (en) Chinese medicine composition for treating amygdalitis and pharyngitis
CN101829287B (en) Traditional Chinese medicine composition for treating pediatric pneumonia
CN103394008B (en) Traditional Chinese medicine for treating wind-cold attacking lung-type cough
CN104940485A (en) Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof
CN102988851B (en) Chinese medicine composition for treating hemoptysis and preparation method of Chinese medicine composition
CN102091250A (en) Traditional Chinese medicine for treating acute tonsillitis
CN102784380A (en) Traditional Chinese medicine preparation for treating pertussis
CN104840855A (en) Traditional Chinese medicine composition for treating pulmonary tuberculosis
CN104623555A (en) Traditional Chinese medicine preparation for treating acute asthmatic bronchitis and preparation method thereof
CN104288477A (en) Traditional Chinese medicine preparation curing infantile asthma
CN103405602A (en) Medicament for treating asthma
CN105362548A (en) Traditional Chinese medicine for treating allergic asthma
CN103142733A (en) Chinese medicine composition for treating upper respiratory infection
CN103417809B (en) TCM preparation for treatment of thrush in infants and children
CN106620205A (en) Externally-used traditional Chinese medicine for foot bath to treat pediatric fever
CN102319387B (en) Traditional Chinese medicine composition for treating chronic cough
CN105327182A (en) Medicine for treating child pertussis and preparation method thereof
CN102949509A (en) Pure traditional Chinese medical health protection syrup for clearing lung heat and stopping cough and preparation method thereof
CN104524256A (en) Traditional Chinese medicine for treating viral pneumonia
CN103463444B (en) Traditional Chinese medicine composition for treating phlegm stagnation cross-resistance type acnes
CN103494924B (en) Chinese medicine composition for treating damp-heat stagnation acne
CN103251925B (en) Traditional Chinese medicine pill for treating diphtheria
CN100411682C (en) Medicament for treating chronic bronchitis and preparation method thereof
CN102727614B (en) Chinese-western medicine preparation for treating chronic obstructive pulmonary disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160302

RJ01 Rejection of invention patent application after publication